View the PDF

Includes: Tailgating With Dr. Digital 2025, Prostate Cancer Stage Increasing, Survival Gains Slowing in the United States, Carotuximab plus apalutamide demonstrates promising PFS in mCRPC, The Safety of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer, Molecular test helps tailor chemotherapy for advanced prostate cancer patients, Diode laser enucleation prostate for benign prostatic hyperplasia: outcomes of the Leonardi ejaculation sparing technique, Trial Proves Biparametric MRI Is Accurate for Prostate Cancer Diagnosis, Risk Model for Lymph Node-Positive Prostate Cancer After Radical Prostatectomy, FDA greenlights phase 1 trial of alpha radioligand therapy in mCRPC, Pre-existing Depression Linked to Lower Survival Among Patients With Prostate Cancer, Reproducibility of Statistically Significant Phase III Oncology Trials, FDA approves 3-month formulation of leuprolide mesylate for advanced prostate cancer, How to keep your prostate healthy and lower your risk of developing serious problems, Chronic administration of the hydrogen sulfide prodrug SG1002 partially protects against erectile dysfunction resulting from long-term androgen deprivation, 2025 PCRI Men’s Health Conference, and more.